Preparation and Antitumor Activity of CS5931, A Novel Polypeptide from Sea Squirt Ciona Savignyi. 2016

Xiaoshuang Chen, and Huanli Xu, and Bo Li, and Feng Wang, and Xiaoliang Chen, and Dexin Kong, and Xiukun Lin
School of Pharmacy, Tianjin Medical University, Tianjin 300070, China. chenxiaoshuang2012@126.com.

CS5931 is a novel anticancer agent isolated from the sea squirt Ciona savignyi. However, its content in the species is very low, and developing a novel approach for production of the polypeptide is promising. In the present study, we expressed and purified the polypeptide from E. coli, and the fermentation conditions were studied using response surface methodology. The yield of CS5931 was increased from 2.0 to 7.5 mg/L. The denaturing and renaturation conditions were also studied. Using the optimized renaturation condition, the anticancer activity of refolding CS5931 was increased significantly; the value of IC50 was decreased from 23.2 to 11.6 μM. In vivo study using xenograft nude mice bearing HCT116 cancer cells revealed that CS5931 was able to inhibit the growth of tumor significantly. The study provides a useful approach for obtaining enough amount of CS5931 for further study. This study is also important for developing the polypeptide as a novel anticancer agent.

UI MeSH Term Description Entries
D008819 Mice, Nude Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses. Athymic Mice,Mice, Athymic,Nude Mice,Mouse, Athymic,Mouse, Nude,Athymic Mouse,Nude Mouse
D003110 Colonic Neoplasms Tumors or cancer of the COLON. Cancer of Colon,Colon Adenocarcinoma,Colon Cancer,Cancer of the Colon,Colon Neoplasms,Colonic Cancer,Neoplasms, Colonic,Adenocarcinoma, Colon,Adenocarcinomas, Colon,Cancer, Colon,Cancer, Colonic,Cancers, Colon,Cancers, Colonic,Colon Adenocarcinomas,Colon Cancers,Colon Neoplasm,Colonic Cancers,Colonic Neoplasm,Neoplasm, Colon,Neoplasm, Colonic,Neoplasms, Colon
D005285 Fermentation Anaerobic degradation of GLUCOSE or other organic nutrients to gain energy in the form of ATP. End products vary depending on organisms, substrates, and enzymatic pathways. Common fermentation products include ETHANOL and LACTIC ACID. Fermentations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077155 Granulins Small, cysteine-rich peptides generated by the proteolytic cleavage of progranulin. Granulin peptides are each composed of a granulin-motif, while paragranulin is composed of a half-granulin motif. The mammalian granulins are named granulin 1-7 for their sequence order in the progranulin propeptide, and are alternately named granulin G, F, B, A, C, D, and E; or epithelin 7, 6, 2, 1, 3, 4, and 5, i.e. granulin 1 aka granulin G aka epithelin 7, etc. Epithelin,Granulin,Epithelin 1,Epithelin 2,Epithelin 3,Epithelin 4,Epithelin 5,Epithelin-1,Epithelin-2,Epithelin2,Epithelins,Granulin (123-179),Granulin (206-261),Granulin 1,Granulin 2,Granulin 3,Granulin 4,Granulin 5,Granulin 6,Granulin 7,Granulin A,Granulin B,Granulin C,Granulin D,Granulin E,Granulin F,Granulin G,Granulin Peptide (281-336),Granulin Peptide (58 -113),Granulin Peptides,Granulin-3,Granulin3,Paragranulin,5, Granulin
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D014561 Urochordata A subphylum of chordates intermediate between the invertebrates and the true vertebrates. It includes the Ascidians. Ascidia,Tunicata,Ascidiacea,Ascidians,Sea Squirts,Tunicates,Urochordates,Ascidian,Sea Squirt,Squirt, Sea,Tunicate,Urochordate
D045325 HCT116 Cells Human COLORECTAL CARCINOMA cell line. HCT 116 Cells,HCT-116 Cells,Cell, HCT 116,Cell, HCT-116,Cell, HCT116,Cells, HCT 116,Cells, HCT-116,Cells, HCT116,HCT 116 Cell,HCT-116 Cell,HCT116 Cell
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

Xiaoshuang Chen, and Huanli Xu, and Bo Li, and Feng Wang, and Xiaoliang Chen, and Dexin Kong, and Xiukun Lin
September 2012, Isotopes in environmental and health studies,
Xiaoshuang Chen, and Huanli Xu, and Bo Li, and Feng Wang, and Xiaoliang Chen, and Dexin Kong, and Xiukun Lin
September 2017, International journal of systematic and evolutionary microbiology,
Xiaoshuang Chen, and Huanli Xu, and Bo Li, and Feng Wang, and Xiaoliang Chen, and Dexin Kong, and Xiukun Lin
March 2014, Marine drugs,
Xiaoshuang Chen, and Huanli Xu, and Bo Li, and Feng Wang, and Xiaoliang Chen, and Dexin Kong, and Xiukun Lin
January 2022, International journal of biological macromolecules,
Xiaoshuang Chen, and Huanli Xu, and Bo Li, and Feng Wang, and Xiaoliang Chen, and Dexin Kong, and Xiukun Lin
December 2009, Cold Spring Harbor protocols,
Xiaoshuang Chen, and Huanli Xu, and Bo Li, and Feng Wang, and Xiaoliang Chen, and Dexin Kong, and Xiukun Lin
April 1997, Biochimica et biophysica acta,
Xiaoshuang Chen, and Huanli Xu, and Bo Li, and Feng Wang, and Xiaoliang Chen, and Dexin Kong, and Xiukun Lin
December 2009, Cold Spring Harbor protocols,
Xiaoshuang Chen, and Huanli Xu, and Bo Li, and Feng Wang, and Xiaoliang Chen, and Dexin Kong, and Xiukun Lin
December 2009, Cold Spring Harbor protocols,
Xiaoshuang Chen, and Huanli Xu, and Bo Li, and Feng Wang, and Xiaoliang Chen, and Dexin Kong, and Xiukun Lin
December 2009, Cold Spring Harbor protocols,
Xiaoshuang Chen, and Huanli Xu, and Bo Li, and Feng Wang, and Xiaoliang Chen, and Dexin Kong, and Xiukun Lin
September 2012, Clinical colorectal cancer,
Copied contents to your clipboard!